For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report.
While it revealed that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation plan which could make her one of the highest-paid chief executives in the industry this year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,